SKIN CANCER DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Drug Type
     • Market Snippet, By Cancer Type
     • Market Snippet, By Route of Administration
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Increasing incidence of skin cancers
     • High costs of targeted therapies
     • Combination therapies
   • Key Highlights
   • Regulatory Scenario
   • Recent Trends
   • Product Launches/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Mergers, Acquisitions, and Collaborations
4. Global Skin Cancer Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
   • COVID-19 Epidemiology
   • Supply Side and Demand Side Analysis
   • Economic Impact
5. Global Skin Cancer Drugs Market, By Drug Type, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019 – 2030
     • Segment Trends
   • Chemotherapy Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
   • Targeted Therapy Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
   • Immunotherapy Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
   • Hormone Therapy Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
   • Others (Photodynamic Therapy, Cryotherapy and Others)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
6. Global Skin Cancer Drugs Market, By Cancer Type, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019 – 2030
     • Segment Trends
   • Basal cell carcinoma
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
   • Squamous cell carcinoma
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
   • Melanoma
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
   • Others (Kaposi's sarcoma, Mycosis fungoides and Others)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
7. Global Skin Cancer Drugs Market, By Route of Administration, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019 – 2030
     • Segment Trends
   • Topical
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
   • Oral
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
   • Injectable
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
   • Others (Surgical procedures, radiation therapy and Others)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
8. Global Skin Cancer Drugs Market, By Distribution Channel, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019 – 2030
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
9. Global Skin Cancer Drugs Market, By Region, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, By Sub-region, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, For Sub-region, 2019 –2030
     • Country Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
       • U.S.
       • Canada
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
       • Brazil
       • Argentina
       • Mexico
       • Rest of Latin America
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
       • Germany
       • U.K.
       • Spain
       • France
       • Italy
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
       • China
       • India
       • Japan
       • Australia
       • South Korea
       • ASEAN
       • Rest of Asia Pacific
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
       • South Africa
       • North Africa
       • Central Africa
10. Competitive Landscape
    • Company Profile
    • Novartis
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Roche
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Amgen
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Pfizer
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sun Pharma
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bristol-Myers Squibb
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AstraZeneca
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Valeant
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Daiichi Sankyo
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical
      • Company Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • LEO Pharma
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Mylan N.V.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Regeneron
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Eli Lilly
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bayer
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Gilead Sciences
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Astellas Pharma
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Analyst Views
11. Section
    • References
    • Research Methodology
    • About us

*Browse 25 market data tables and 29 figures on “Global Skin Cancer Drugs Market” - Global forecast to 2030